Antibodies conjugated to death receptor agonists have been reported to induce apoptosis in GBM cell lines, for example, the scFvM58–sTRAIL fusion, which has been shown to selectively target GBM cells that express multidrug resistance protein 3 (62). The gene discussed is ABCB4; the disease is glioblastoma.